- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/655 - Somatostatines
Détention brevets de la classe C07K 14/655
Brevets de cette classe: 146
Historique des publications depuis 10 ans
|
8
|
7
|
9
|
7
|
3
|
8
|
2
|
2
|
10
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Glytech, Inc. | 64 |
8 |
| BCN Peptides, S.A. | 32 |
6 |
| Braasch Biotech LLC | 8 |
5 |
| Immunwork Inc. | 26 |
5 |
| The Salk Institute for Biological Studies | 451 |
5 |
| Tel Hashomer Medical Research Infrastructure and Services Ltd. | 329 |
5 |
| Ipsen Pharma S.A.S. | 367 |
4 |
| University Hospital Basel | 15 |
4 |
| Adepthera LLC | 11 |
4 |
| UCL Business Ltd | 644 |
4 |
| The Administrators of the Tulane Educational Fund | 406 |
3 |
| Camurus AB | 149 |
3 |
| Ipsen Manufacturing Ireland Limited | 7 |
3 |
| Italfarmaco SpA | 153 |
3 |
| Recordati AG | 39 |
3 |
| Taurus Biosciences, LLC | 8 |
3 |
| Novartis AG | 10467 |
2 |
| The Regents of the University of California | 20473 |
2 |
| AmideBio, LLC | 16 |
2 |
| British Columbia Cancer Agency Branch | 185 |
2 |
| Autres propriétaires | 70 |